Analysts' Actions: AKAM ANF BID MNKD WDC

NEW YORK (TheStreet) -- RATINGS CHANGES

Autodesk (ADSK) was upgraded to buy at Canaccord Genuity. $60 12-month price target. The company is leveraged to tailwinds in commercial construction, Canaccord said.

Akamai (AKAM) was upgraded to outperform from sector perform at Pacific Crest. $65 12-month price target. Media traffic growth continues to accelerate, Pacific Crest said.

Abercrombie & Fitch (ANF) was downgraded to hold at TheStreet Ratings.

Sotheby's (BID) was downgraded to hold at TheStreet Ratings.

IMS Health (IMS) was initiated with an equal weight rating at Barclays. $27 12-month price target. Consolidation in the pharma client could constrain multiples, Barclays said.

Lear (LEA) was upgraded at to buy from hold at Deutsche Bank. $100 12-month price target. The seating business may be at an inflection point, said Deutsche Bank.

Legg Mason (LM) was upgraded to buy at Citigroup. The company should see an inflection point in asset flows, Citi said.

Mannkind (MNKD) was upgraded to neutral from underweight at Piper Jaffray. $6.50 12-month price target. The company had a positive FDA panel and the valuation is more attractive ahead of the July 15 PDUFA, said Piper Jaffray.

MWI Veterinary Supply (MWIV) was initiated with a buy rating at UBS. $168 12-month price target. This was a valuation call, with the recent acquisition being more accretive than initially realized, UBS said.

Nielsen Holdings (NLSN) was initiated with an overweight rating at Barclays. $55 12-month price target. The company is driven by growth in the global middle class, modernization of global trade and media fragmentation, said Barclays.

Trulia (TRLA) was downgraded to sell at TheStreet Ratings.

Western Digital (WDC) was upgraded to overweight from equal weight at Barclays. $98 12-month price target. Catalysts include increased cash return and MOFCOM granting full approval for Western Digital to integrate its two subsidiaries, Barclays said.

 
Zimmer ( ZMH) was upgraded to strong buy from hold at Needham. The BMET purchase should add to earnings, and both companies can gain market share in the next year, Needham said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

>>Read More: Volkswagen Launches the People's Electric Car

>>Read More: Sozzi: Is Macy's Really Performing National Magic Acts?

>>Read More: Malware's Boom for Microsoft

More from Stocks

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Jim Cramer: Reports of Attempted Trade Truce With China Are False

GM's New Chevy Blazer Looks as Lame as the Stock Market Right Now

GM's New Chevy Blazer Looks as Lame as the Stock Market Right Now

Video: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Video: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

ABIOMED Stock Should Rise Some 10% From Here, Piper Jaffray Analyst Says

ABIOMED Stock Should Rise Some 10% From Here, Piper Jaffray Analyst Says